Deere And Co Q2 22 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 5/20/2022 6:02 AM ET

Deere And Co (DE) will host a conference call at 10:00 AM ET on May 20, 2022, to discuss Q2 22 earnings results. Deere And Co is scheduled to report results on Friday, May 20, before market open.

To access the live webcast, log on to https://investor.deere.com/home/default.aspx

For comments and feedback contact: editorial@rttnews.com

Business News

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Latest Updates on COVID-19

Covid Conditions Improving Nationally In US, Data Shows

Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids

Synairgen Reports Positive 60 And 90-day Long COVID Data From Phase 3 SNG001 Trial; Stock Up

U.S. Covid Cases Fall 29% In Last Fortnight

AstraZeneca's Evusheld Gets CHMP Recommendation For EU Approval To Treat COVID-19

COVID-19: Drugs in Development

GM Delays Return-to-Office Plan After Employee Backlash

Ford Asks For New Trial After $1.7 Bln Jury Verdict In Truck Rollover Case

Macy's To Hire More Than 41,000 Seasonal Colleagues

Ladders Sold With Bunk Bed And Hutch Sets Recalled

Lyft To Offer Rides For Indeed's Ready To Work Program

Pool And Spa Drain Covers Sold At Amazon Recalled

Deere And Co Q2 22 Earnings Conference Call At 10:00 AM ET

GM Delays Return-to-Office Plan After Employee Backlash

Ford Asks For New Trial After $1.7 Bln Jury Verdict In Truck Rollover Case

Macy's To Hire More Than 41,000 Seasonal Colleagues

Ladders Sold With Bunk Bed And Hutch Sets Recalled

Lyft To Offer Rides For Indeed's Ready To Work Program

Pool And Spa Drain Covers Sold At Amazon Recalled

Ionis: AstraZeneca Decides Not To Advance ION449 Into Phase 3 Based On Pre-specified Criteria

Lyft To Offer Rides For Indeed's Ready To Work Program

SSP Group Sees Strong Recovery In Q4 Revenues, Lifts FY22 Outlook; Says Confident In FY23

AstraZeneca : Japan Approves Koselugo For Rare Genetic Disease In Paediatric Patients

Bausch Health, Glenmark Specialty Say Health Canada Approves RYALTRIS

Avenue Therapeutics Sinks 25%; Shares Start Trading After Reverse Stock Split

AstraZeneca Announces Approval For Ultomiris By The European Commission

Chase, DoorDash To Launch DoorDash Credit Card - Quick Facts

Artivion Stops PROACT Xa Clinical Trial With Apixaban; Confirms Positive Top-line Outlook

Innate : Data From Phase 2 Trial Of Lacutamab In Advanced Mycosis Fungoides Shows Clinical Activity

Valneva In Talks With Partner For Funding To Develop Potential Second-generation COVID-19 Vaccine

Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

Oxford Metrics Says Not To Meet FY22 Market View; Stock Down

TD SYNNEX Q3 Profit Spikes, Beats Estimates

Progress Software Corp Q3 Profit Decreases, but beats estimates

FlyBlade India And Eve Air Mobility Partner To Create Urban Air Mobility Ecosystem In India

Glencore To Acquire Newmont's Shareholding In MARA Project

Innocoll To Make $2 Mln Payment To DURECT On First Commercial Sale Of POSIMIR

TreeHouse Foods Recalls Italian Dressing Due To Undeclared Allergens

Babcock Says Trading Continues To Be In Line With Board's FY Expectations

Oracle Agrees To Pay More Than $23 Mln To Settle SEC Bribery Case

Frasers Now Intends To Seek To Buy Addl MySale Shares By Means Of Market Or Other Purchases

Ionis: AstraZeneca Decides Not To Advance ION449 Into Phase 3 Based On Pre-specified Criteria

Ascent Solar CEO Victor Lee Resigns